These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 24931572)

  • 1. Outpatient glycemic control with a bionic pancreas in type 1 diabetes.
    Russell SJ; El-Khatib FH; Sinha M; Magyar KL; McKeon K; Goergen LG; Balliro C; Hillard MA; Nathan DM; Damiano ER
    N Engl J Med; 2014 Jul; 371(4):313-325. PubMed ID: 24931572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
    El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
    Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nocturnal glucose control with an artificial pancreas at a diabetes camp.
    Phillip M; Battelino T; Atlas E; Kordonouri O; Bratina N; Miller S; Biester T; Stefanija MA; Muller I; Nimri R; Danne T
    N Engl J Med; 2013 Feb; 368(9):824-33. PubMed ID: 23445093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
    ; Russell SJ; Beck RW; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro CA; Li Z; Calhoun P; Wadwa RP; Buckingham B; Zhou K; Daniels M; Raskin P; White PC; Lynch J; Pettus J; Hirsch IB; Goland R; Buse JB; Kruger D; Mauras N; Muir A; McGill JB; Cogen F; Weissberg-Benchell J; Sherwood JS; Castellanos LE; Hillard MA; Tuffaha M; Putman MS; Sands MY; Forlenza G; Slover R; Messer LH; Cobry E; Shah VN; Polsky S; Lal R; Ekhlaspour L; Hughes MS; Basina M; Hatipoglu B; Olansky L; Bhangoo A; Forghani N; Kashmiri H; Sutton F; Choudhary A; Penn J; Jafri R; Rayas M; Escaname E; Kerr C; Favela-Prezas R; Boeder S; Trikudanathan S; Williams KM; Leibel N; Kirkman MS; Bergamo K; Klein KR; Dostou JM; Machineni S; Young LA; Diner JC; Bhan A; Jones JK; Benson M; Bird K; Englert K; Permuy J; Cossen K; Felner E; Salam M; Silverstein JM; Adamson S; Cedeno A; Meighan S; Dauber A
    N Engl J Med; 2022 Sep; 387(13):1161-1172. PubMed ID: 36170500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
    Brown SA; Kovatchev BP; Raghinaru D; Lum JW; Buckingham BA; Kudva YC; Laffel LM; Levy CJ; Pinsker JE; Wadwa RP; Dassau E; Doyle FJ; Anderson SM; Church MM; Dadlani V; Ekhlaspour L; Forlenza GP; Isganaitis E; Lam DW; Kollman C; Beck RW;
    N Engl J Med; 2019 Oct; 381(18):1707-1717. PubMed ID: 31618560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Insulin-Only Bionic Pancreas Pivotal Trial Extension Study: A Multi-Center Single-Arm Evaluation of the Insulin-Only Configuration of the Bionic Pancreas in Adults and Youth with Type 1 Diabetes.
    Lynch J; Kanapka LG; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro C; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 Oct; 24(10):726-736. PubMed ID: 36173238
    [No Abstract]   [Full Text] [Related]  

  • 8. Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes.
    El-Khatib FH; Russell SJ; Magyar KL; Sinha M; McKeon K; Nathan DM; Damiano ER
    J Clin Endocrinol Metab; 2014 May; 99(5):1701-11. PubMed ID: 24483160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care.
    Bally L; Thabit H; Hartnell S; Andereggen E; Ruan Y; Wilinska ME; Evans ML; Wertli MM; Coll AP; Stettler C; Hovorka R
    N Engl J Med; 2018 Aug; 379(6):547-556. PubMed ID: 29940126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    Ware J; Allen JM; Boughton CK; Wilinska ME; Hartnell S; Thankamony A; de Beaufort C; Schierloh U; Fröhlich-Reiterer E; Mader JK; Kapellen TM; Rami-Merhar B; Tauschmann M; Nagl K; Hofer SE; Campbell FM; Yong J; Hood KK; Lawton J; Roze S; Sibayan J; Bocchino LE; Kollman C; Hovorka R;
    N Engl J Med; 2022 Jan; 386(3):209-219. PubMed ID: 35045227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Threshold-based insulin-pump interruption for reduction of hypoglycemia.
    Bergenstal RM; Klonoff DC; Garg SK; Bode BW; Meredith M; Slover RH; Ahmann AJ; Welsh JB; Lee SW; Kaufman FR;
    N Engl J Med; 2013 Jul; 369(3):224-32. PubMed ID: 23789889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes.
    Stewart ZA; Wilinska ME; Hartnell S; Temple RC; Rayman G; Stanley KP; Simmons D; Law GR; Scott EM; Hovorka R; Murphy HR
    N Engl J Med; 2016 Aug; 375(7):644-54. PubMed ID: 27532830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial.
    Messer LH; Buckingham BA; Cogen F; Daniels M; Forlenza G; Jafri RZ; Mauras N; Muir A; Wadwa RP; White PC; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro CA; Li Z; Marak MC; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 Oct; 24(10):712-725. PubMed ID: 36173237
    [No Abstract]   [Full Text] [Related]  

  • 15. Performance and safety of an integrated bihormonal artificial pancreas for fully automated glucose control at home.
    Blauw H; van Bon AC; Koops R; DeVries JH;
    Diabetes Obes Metab; 2016 Jul; 18(7):671-7. PubMed ID: 26996542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.
    Haidar A; Legault L; Matteau-Pelletier L; Messier V; Dallaire M; Ladouceur M; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):595-604. PubMed ID: 26066705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Bihormonal Bionic Pancreas Improves Glycemic Control in Individuals With Hyperinsulinism and Postpancreatectomy Diabetes: A Pilot Study.
    Rayannavar A; Mitteer LM; Balliro CA; El-Khatib FH; Lord KL; Hawkes CP; Ballester LS; Damiano ER; Russell SJ; De León DD
    Diabetes Care; 2021 Nov; 44(11):2582-2585. PubMed ID: 34518377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Home Use of an Artificial Beta Cell in Type 1 Diabetes.
    Thabit H; Tauschmann M; Allen JM; Leelarathna L; Hartnell S; Wilinska ME; Acerini CL; Dellweg S; Benesch C; Heinemann L; Mader JK; Holzer M; Kojzar H; Exall J; Yong J; Pichierri J; Barnard KD; Kollman C; Cheng P; Hindmarsh PC; Campbell FM; Arnolds S; Pieber TR; Evans ML; Dunger DB; Hovorka R
    N Engl J Med; 2015 Nov; 373(22):2129-2140. PubMed ID: 26379095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.